Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability

Morin (3,5,7,2′,4′-pentahydroxyflavone; MR) is a bioactive plant polyphenol whose therapeutic efficacy is hindered by its poor biopharmaceutical properties. The purpose of this study was to develop a nanoparticle (NP) formulation to enhance the bioactivity and oral bioavailability of MR. The nanopre...

Full description

Bibliographic Details
Main Authors: Suhair Sunoqrot, Malak Alkurdi, Abdel Qader Al Bawab, Alaa M. Hammad, Rabab Tayyem, Ali Abu Obeed, Mohammed Abufara
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016423000920
_version_ 1797813763517186048
author Suhair Sunoqrot
Malak Alkurdi
Abdel Qader Al Bawab
Alaa M. Hammad
Rabab Tayyem
Ali Abu Obeed
Mohammed Abufara
author_facet Suhair Sunoqrot
Malak Alkurdi
Abdel Qader Al Bawab
Alaa M. Hammad
Rabab Tayyem
Ali Abu Obeed
Mohammed Abufara
author_sort Suhair Sunoqrot
collection DOAJ
description Morin (3,5,7,2′,4′-pentahydroxyflavone; MR) is a bioactive plant polyphenol whose therapeutic efficacy is hindered by its poor biopharmaceutical properties. The purpose of this study was to develop a nanoparticle (NP) formulation to enhance the bioactivity and oral bioavailability of MR. The nanoprecipitation technique was employed to encapsulate MR in lipid-cored poly(lactide-co-glycolide) (PLGA) NPs. The optimal NPs were about 200 nm in size with an almost neutral surface charge and a loading efficiency of 82%. The NPs exhibited sustained release of MR within 24 h. In vitro antioxidant assays showed that MR encapsulation did not affect its antioxidant activity. On the other hand, anti-inflammatory assays in lipopolysaccharide-stimulated macrophages revealed a superior anti-inflammatory activity of MR NPs compared to free MR. Furthermore, oral administration of MR NPs to mice at a single dose of 20 mg/kg MR achieved a 5.6-fold enhancement in bioavailability and a prolongation of plasma half-life from 0.13 to 0.98 h. The results of this study present a promising NP formulation for MR which can enhance its oral bioavailability and bioactivity for the treatment of different diseases such as inflammation.
first_indexed 2024-03-13T07:57:34Z
format Article
id doaj.art-e0ff0138ea6a4fe89a2e864b9595633f
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-03-13T07:57:34Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-e0ff0138ea6a4fe89a2e864b9595633f2023-06-02T04:22:47ZengElsevierSaudi Pharmaceutical Journal1319-01642023-06-01316845853Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailabilitySuhair Sunoqrot0Malak Alkurdi1Abdel Qader Al Bawab2Alaa M. Hammad3Rabab Tayyem4Ali Abu Obeed5Mohammed Abufara6Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan; Corresponding author at: Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman 11733, Jordan.Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanACDIMA Biocenter, Amman 11190, JordanACDIMA Biocenter, Amman 11190, JordanACDIMA Biocenter, Amman 11190, JordanMorin (3,5,7,2′,4′-pentahydroxyflavone; MR) is a bioactive plant polyphenol whose therapeutic efficacy is hindered by its poor biopharmaceutical properties. The purpose of this study was to develop a nanoparticle (NP) formulation to enhance the bioactivity and oral bioavailability of MR. The nanoprecipitation technique was employed to encapsulate MR in lipid-cored poly(lactide-co-glycolide) (PLGA) NPs. The optimal NPs were about 200 nm in size with an almost neutral surface charge and a loading efficiency of 82%. The NPs exhibited sustained release of MR within 24 h. In vitro antioxidant assays showed that MR encapsulation did not affect its antioxidant activity. On the other hand, anti-inflammatory assays in lipopolysaccharide-stimulated macrophages revealed a superior anti-inflammatory activity of MR NPs compared to free MR. Furthermore, oral administration of MR NPs to mice at a single dose of 20 mg/kg MR achieved a 5.6-fold enhancement in bioavailability and a prolongation of plasma half-life from 0.13 to 0.98 h. The results of this study present a promising NP formulation for MR which can enhance its oral bioavailability and bioactivity for the treatment of different diseases such as inflammation.http://www.sciencedirect.com/science/article/pii/S1319016423000920Anti-inflammatoryBioavailabilityMorinNanoencapsulationPLGA
spellingShingle Suhair Sunoqrot
Malak Alkurdi
Abdel Qader Al Bawab
Alaa M. Hammad
Rabab Tayyem
Ali Abu Obeed
Mohammed Abufara
Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability
Saudi Pharmaceutical Journal
Anti-inflammatory
Bioavailability
Morin
Nanoencapsulation
PLGA
title Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability
title_full Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability
title_fullStr Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability
title_full_unstemmed Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability
title_short Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability
title_sort encapsulation of morin in lipid core plga shell nanoparticles significantly enhances its anti inflammatory activity and oral bioavailability
topic Anti-inflammatory
Bioavailability
Morin
Nanoencapsulation
PLGA
url http://www.sciencedirect.com/science/article/pii/S1319016423000920
work_keys_str_mv AT suhairsunoqrot encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability
AT malakalkurdi encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability
AT abdelqaderalbawab encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability
AT alaamhammad encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability
AT rababtayyem encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability
AT aliabuobeed encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability
AT mohammedabufara encapsulationofmorininlipidcoreplgashellnanoparticlessignificantlyenhancesitsantiinflammatoryactivityandoralbioavailability